chevron-down Created with Sketch Beta.
May 20, 2022

FDA Approves First Direct-to-Consumer COVID-19 Test that Also Detects Flu and RSV

On May 16, FDA  issued an emergency use authorization for the first non-prescription, direct-to-consumer COVID-19 test that allows individuals to collect a nasal swab at home for testing in a laboratory. Testing will be performed by LabCorp and can simultaneously diagnose multiple respiratory viruses including COVID-19, respiratory syncytial virus (RSV), and Influenza A and B. 

The material in all ABA publications is copyrighted and may be reprinted by permission only. Request reprint permission here.